Related references
Note: Only part of the references are listed.MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells
Xiaoping Zhang et al.
ONCOGENE (2019)
miR-483-5p decreases the radiosensitivity of nasopharyngeal carcinoma cells by targeting DAPK1
Yunhong Tian et al.
LABORATORY INVESTIGATION (2019)
NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway
Cheng-Liang Yang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer
Claire Agosta et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
The value of serum survivin level in early diagnosis of cancer
Meral Gunaldi et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
Identification of biomarker microRNAs for predicting the response colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network
Yaqun Zhu et al.
ONCOTARGET (2017)
MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinoma
Shaohui Tang et al.
ONCOTARGET (2017)
miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5
Zhi-Gang Yang et al.
INTERNATIONAL BRAZ J UROL (2017)
NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second promoter in human gastrointestinal cancers
Akihiro Yamamura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
NDRG2 promoted secreted miR-375 in microvesicles shed from M1 microglia, which induced neuron damage
Li-li Tang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
miR-483-3p plays an oncogenic role in esophageal squamous cell carcinoma by targeting tumor suppressor EI24
Jiaojiao Ma et al.
CELL BIOLOGY INTERNATIONAL (2016)
IGF2-derived miR-483 mediated oncofunction by suppressing DLC-1 and associated with colorectal cancer
Hengmi Cui et al.
ONCOTARGET (2016)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Aberrant Regulation and Function of MicroRNAs in Cancer
Brian D. Adams et al.
CURRENT BIOLOGY (2014)
Clinical relevance of circulating cell-free microRNAs in cancer
Heidi Schwarzenbach et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Colorectal Cancer with Potentially Resectable Hepatic Metastases: Optimizing Treatment
Mathias Worni et al.
CURRENT ONCOLOGY REPORTS (2014)
MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1
Li Wang et al.
FEBS LETTERS (2012)
Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650
Li Feng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications
Veerle Melotte et al.
FASEB JOURNAL (2010)
miRecords: an integrated resource for microRNA-target interactions
Feifei Xiao et al.
NUCLEIC ACIDS RESEARCH (2009)
N-myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation
YC Deng et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation
EC Lai
NATURE GENETICS (2002)